By John Vandermosten, CFANASDAQ: HURAREAD THE FULL HURA RESEARCH REPORTOperational and Financial ResultsOn May 15th, 2026, TuHURA Biosciences, Inc. (NASDAQ:…
By John Vandermosten, CFANASDAQ: HURAREAD THE FULL HURA RESEARCH REPORTOperational and Financial ResultsOn April 1st, 2026, TuHURA Biosciences, Inc. (NASDAQ:…
SOUTH SAN FRANCISCO, Kalifornien & MÜNCHEN--(BUSINESS WIRE)--Spruce Biosciences, Inc. (Nasdaq: SPRB) („Spruce“), ein biopharmazeutisches Unternehmen im Spätstadium, das sich auf…